Clinical Trial Update: Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating irinotecan liposome-based total neoadjuvant therapy for locally advanced rectal cancer, sponsored by Zhejiang Cancer Hospital, is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Irinotecan liposome (liposomal irinotecan)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Locally Advanced Rectal Cancer | Phase 3 | Status: NOT_YET_RECRUITING